Form D · Other
OG DNA Genetics Inc.
San Diego, CA · CIK 0001758472
Offering snapshot reported Dec 7, 2018 · SEC filing
- Reported sold
- $24M Offering amount: $24M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 23, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2018 | Initial | $23,990,000 | No comparison | 38 | SEC filing |
| Nov 14, 2018 | Initial | $11,584,000 | No comparison | 50 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.49M
- Finders' fees
- $0
- Form D file number
- 021-327395
Common Shares
Commissions of $1,391,700 plus fees of $47,700 and expenses of $50,000, totaling $1,489,400, paid solely in connection with distributions outside of U.S.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| KES 7 Capital Inc. | None |
Source: Form D, filed Dec 7, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Hamlin | Executive |
| Rezwan Khan | Executive |
| Donald Wayne Morris | Director, Executive |
| Charles Phillips | Director, Executive |
| Israel Aaron Yarkoni | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
444 W C Street, Suite 400
San Diego, CA, 92101
San Diego, CA, 92101